国家起诉阻止23andMe未经顾客同意向Regeneron出售遗传数据。 States sue to block 23andMe's sale of genetic data to Regeneron without customer consent.

27个州和哥伦比亚特区已提起诉讼,阻止23andMe未经顾客同意出售个人遗传数据。 Twenty-seven states and the District of Columbia have filed a lawsuit to block the sale of personal genetic data by 23andMe without customer consent. 诉讼的目标是拟议向Regeneron制药公司出售2.56亿美元,认为DNA和健康记录等敏感数据不应未经明示同意出售。 The lawsuit targets a proposed $256 million sale to Regeneron Pharmaceuticals, arguing that sensitive data like DNA and health records should not be sold without explicit consent. Regeneron承诺遵守23andMe的隐私政策,但法院指定的隐私监察员将审查这项协议对消费者隐私的影响。 Regeneron promises to comply with 23andMe's privacy policies, but a court-appointed privacy ombudsman will review the deal's impact on consumer privacy.